- ISIN
- US7711951043
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
Highlights
- EPS (TTM)
- $5.42
- PE Ratio
- 9.05
- Total Revenue (TTM)
- $107.65B
- Gross Profit (TTM)
- $79.28B
- EBITDA (TTM)
- $31.01B
- Year Range
- $37.51 - $60.85
- Target Price
- $57.00
- ROA (TTM)
- 17.27%
- ROE (TTM)
- 51.44%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
RHHBY Performance Chart
Roche Holding AG (RHHBY) is down 1.9% since the beginning of the year. At $49 per share, RHHBY is trading 19.4% below its 52-week high of $61. Investors who bought $1,000 worth of RHHBY shares 5 years ago would now be looking at an investment worth $1,327.
Loading charts...
Returns By Period
Roche Holding AG (RHHBY) has returned -1.92% so far this year and 24.33% over the past 12 months. Over the last ten years, RHHBY has returned 7.15% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Roche Holding AG
- 1D
- -2.29%
- 1M
- -3.78%
- YTD
- -1.92%
- 6M
- 3.86%
- 1Y
- 24.33%
- 3Y*
- 10.46%
- 5Y*
- 5.82%
- 10Y*
- 7.15%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
RHHBY Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2001, RHHBY's average daily return is +0.04%, while the average monthly return is +0.84%. At this rate, an investment would double in approximately 6.9 years.
Historically, 56% of months were positive and 44% were negative. The best month was Mar 2009 with a return of +25.4%, while the worst month was Feb 2009 at -20.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.
On a daily basis, RHHBY closed higher 46% of trading days. The best single day was May 8, 2001 with a return of +13.6%, while the worst single day was Mar 17, 2003 at -13.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 10.04% | 4.93% | -13.96% | 2.35% | 2.99% | -6.35% | -1.92% | ||||||
| 2025 | 12.53% | 6.34% | 1.93% | -0.92% | -1.15% | 1.14% | -4.54% | 4.78% | 2.55% | -3.37% | 18.39% | 7.82% | 52.86% |
| 2024 | -3.01% | -6.86% | 1.53% | -6.58% | 7.34% | 8.31% | 16.84% | 4.49% | -5.62% | -2.85% | -6.62% | -3.75% | 0.23% |
| 2023 | 0.00% | -7.92% | 3.17% | 9.37% | 0.94% | -3.51% | 1.31% | -5.35% | -7.37% | -4.72% | 4.21% | 7.54% | -4.02% |
| 2022 | -6.00% | -2.80% | 7.44% | -6.54% | -7.88% | -1.95% | -0.58% | -2.48% | 0.45% | 1.77% | -1.02% | -4.33% | -22.21% |
| 2021 | -0.98% | -5.32% | 0.61% | 0.37% | 7.49% | 7.38% | 2.70% | 4.06% | -9.46% | 6.29% | 0.93% | 5.97% | 20.20% |
Benchmark Metrics
Roche Holding AG has an annualized alpha of 6.89%, beta of 0.48, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since January 03, 2001.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (60.24%) than losses (50.04%) - typical of diversified or defensive assets.
- Beta of 0.48 may look defensive, but with R2 of 0.15 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 6.89%
- Beta
- 0.48
- R²
- 0.15
- Upside Capture
- 60.24%
- Downside Capture
- 50.04%
Return for Risk
Risk / Return Rank
RHHBY ranks 65 for risk / return — better than 65% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Roche Holding AG (RHHBY) and compare them to S&P 500 Index.
| RHHBY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.91 | 2.39 | -1.48 |
Sortino ratioReturn per unit of downside risk | 1.50 | 3.25 | -1.75 |
Omega ratioGain probability vs. loss probability | 1.18 | 1.43 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | 1.26 | 3.11 | -1.85 |
Martin ratioReturn relative to average drawdown | 3.16 | 14.38 | -11.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Roche Holding AG provided a 3.16% dividend yield over the last twelve months, with an annual payout of $1.55 per share. The company has been increasing its dividends for 6 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.55 | $1.39 | $1.35 | $1.29 | $1.27 | $0.81 | $0.73 | $0.69 | $1.11 | $1.03 | $1.02 | $1.00 |
Dividend yield | 3.16% | 2.69% | 3.87% | 3.55% | 3.23% | 1.57% | 1.66% | 1.70% | 3.58% | 3.25% | 3.57% | 2.91% |
Monthly Dividends
The table displays the monthly dividend distributions for Roche Holding AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $1.55 | $0.00 | $0.00 | $0.00 | $1.55 | ||||||
| 2025 | $0.00 | $0.00 | $1.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.39 |
| 2024 | $0.00 | $0.00 | $1.35 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.35 |
| 2023 | $0.00 | $0.00 | $1.29 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.29 |
| 2022 | $0.00 | $0.00 | $1.27 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.27 |
| 2021 | $0.00 | $0.00 | $0.81 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.81 |
Dividend Yield & Payout
Dividend Yield
Roche Holding AG has a dividend yield of 3.16%, which is quite average when compared to the overall market.
Payout Ratio
Roche Holding AG has a payout ratio of 73.07%, which is quite average when compared to the overall market. This suggests that Roche Holding AG strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Roche Holding AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Roche Holding AG was 45.73%, occurring on Mar 2, 2009. Recovery took 567 trading sessions.
The current Roche Holding AG drawdown is 16.51%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -45.73%Mar 2009 | 1y 2d | 2y 3mo | 3y 3moFeb 2008 - May 2011 |
2024 bear market2024 | -40.88%May 2024 | 2y 22d | 1y 6mo | 3y 7moApr 2022 - Nov 2025 |
2003 bear market2003 | -40.69%Mar 2003 | 2y 2mo | 9mo 6d | 2y 11moJan 2001 - Dec 2003 |
2016 bear market2016 | -27.32%Dec 2016 | 1y 6mo | 2y 2mo | 3y 9moJun 2015 - Feb 2019 |
COVID crash2020 | -20.28%Mar 2020 | 21d | 1mo 11d | 2mo 2dFeb 2020 - Apr 2020 |
Drawdown Indicators
| RHHBY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.73% | -56.78% | +11.05% |
Max Drawdown (1Y)Largest decline over 1 year | -19.38% | -9.10% | -10.28% |
Max Drawdown (3Y)Largest decline over 3 years | -24.58% | -18.90% | -5.68% |
Max Drawdown (5Y)Largest decline over 5 years | -40.88% | -25.43% | -15.45% |
Max Drawdown (10Y)Largest decline over 10 years | -40.88% | -33.92% | -6.96% |
Current DrawdownCurrent decline from peak | -16.51% | 0.00% | -16.51% |
Average DrawdownAverage peak-to-trough decline | -12.84% | -10.72% | -2.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.71% | 1.97% | +5.74% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Roche Holding AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Roche Holding AG is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for RHHBY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/E ratio of 9.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RHHBY relative to other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with RHHBY
Add Roche Holding AG to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with RHHBY